ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1055

Proteomic and Transcriptomic Analysis of Human Eosinophilic Fasciitis Fibroblasts

Benjamin Chaigne1, Claire Fernandez 2, Morgane le Gall 2, Philippe Chafey 2, Benjamin Saintpierre 2, Virginie Salnot 2, Francois Guillonneau 2, Claire Le Jeunne 3 and Luc Mouthon 4, 1Cochin University Hospital, Paris, France, 2Cochin Institute, Paris, France, 3Paris Descartes University, Cochin Hospital, Internal Medicine department, Paris, France, 4National Referral Center for Rare Systemic Autoimmune Diseases Paris Cochin, Paris, France

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Eosinophilic Fasciitis (Shulman's Disease), proteomics and fibroblasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Eosinophilic fasciitis (EF) is a rare scleroderma-like disorder with less than 200 cases reported. Due to the rarity of the disease, data regarding its pathophysiology are lacking. Herein we aimed at studying the transcriptome and the proteome of EF fibroblasts.

Methods: Skin fibroblasts from EF patients (n=4), systemic sclerosis (SSc) patients (n=4), and healthy controls (HC) (n=4), were cultured and harvested for transcriptomic and proteomic analysis. Analyses were performed using next generation sequencing and label-free quantification, respectfully. Functional analyses were performed using Ingenuity Pathway Analysis and Panther softwares.

Results: Five hundred and nine genes involved in 14 biological processes (BP) and 199 pathways were differentially expressed between EF and control groups. Among them, the circadian clock system (CCS) (p=1.70 10-9), the plasminogen-activating cascade (PAC) (p=3.82 10-5), the FGF signalling pathway (p=1.15 10-4), and the integrin signalling pathway (p=1.33 10-3) were overrepresented. When comparing EF to HC genes, Panther showed overrepresented down-regulated pathway including CCS (p=1.71 10-12), and overrepresented up-regulated pathways such as flavin biosynthesis, (p=9.22 10-4), PAC (p=1.19 10-6), de novo purine biosynthesis (p=1.63 10-3), FGF signalling pathway (p=1.47 10-3) and integrin signalling pathway (p=9.14 10-4). When comparing EF to SSc genes Panther showed overrepresented down-regulated CCS (p=2.51 10-4).

Two hundred and twenty four proteins involved in 10 BP and 126 pathways were differentially expressed between EF and control groups. When comparing EF to HC proteins, Panther showed specific overrepresented up-regulated biological processes such as vesicle-mediated transport (p=4.66 10-5) and intracellular protein transport (p=1.24 10-4), and overrepresented up-regulated pathways such as 5-hydroxytryptamine degradation (5-HTD) (p=1.56 10-4) and overrepresented down-regulated pathways such as heterotrimeric G-protein signalling pathways-rod outer segment photo-transduction (HTGSP) (p=1.24 10-4). When comparing EF to SSc proteins, Panther showed specific overrepresented down-regulated biological processes such as 5-HTD (p=4.48 10-4), and overrepresented down-regulated pathways such as HTGSP (p=1.98 10-4), and ubiquitin proteasome pathway (p =1.05 10-3).

Conclusion: This work described the transcriptome and the proteome of EF fibroblasts and highlighted significant specificities of EF fibroblasts when compared to HC and SSc.


Disclosure: B. Chaigne, None; C. Fernandez, None; M. le Gall, None; P. Chafey, None; B. Saintpierre, None; V. Salnot, None; F. Guillonneau, None; C. Le Jeunne, None; L. Mouthon, None.

To cite this abstract in AMA style:

Chaigne B, Fernandez C, le Gall M, Chafey P, Saintpierre B, Salnot V, Guillonneau F, Le Jeunne C, Mouthon L. Proteomic and Transcriptomic Analysis of Human Eosinophilic Fasciitis Fibroblasts [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/proteomic-and-transcriptomic-analysis-of-human-eosinophilic-fasciitis-fibroblasts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proteomic-and-transcriptomic-analysis-of-human-eosinophilic-fasciitis-fibroblasts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology